» Articles » PMID: 3673517

Cell Kinetics of the Malignant Evolution of Meningothelial Meningioma

Overview
Specialty Neurology
Date 1987 Jan 1
PMID 3673517
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

A meningotheliomatous meningioma occurred in the right parietal parasagittal region of a 43-year-old woman. A total excision was carried out. Three years and 9 months later, one parasagittal and two falx tumors in close proximity recurred and were excised. The falx tumors showed the features of an anaplastic transitional meningioma with increased mitoses. The falx meningioma recurred locally and repeatedly, despite radiation therapy and chemoimmunotherapy. She died 7 years and 8 months after the onset. At autopsy, the tumor was found to have metastasized via the cerebrospinal fluid to the spinal cord and pituitary stalk. Extracranial metastases were not evident. At the fourth craniotomy, bromodeoxyuridine (BrdU) was administered intravenously to label tumor cells in the S phase of the cell cycle. The BrdU-labeled cells accounted for 9.0%; they are usually less than 1% in benign meningiomas. Meningothelial meningiomas with a high labeling index recur rapidly, even after Simpson's grade 2 removal, and treatment for a malignant meningioma should be instituted.

Citing Articles

Metastasis in meningioma.

Enam S, Abdulrauf S, Mehta B, Malik G, Mahmood A Acta Neurochir (Wien). 1996; 138(10):1172-7; discussion 1177-8.

PMID: 8955436 DOI: 10.1007/BF01809747.


The application of 5-bromodeoxyuridine in the management of CNS tumors.

Freese A, ORourke D, Judy K, OConnor M J Neurooncol. 1994; 20(1):81-95.

PMID: 7807187 DOI: 10.1007/BF01057964.


An immunohistochemical study of tissue transglutaminase in gliomas with reference to their cell dying processes.

Iwaki T, Miyazono M, Hitosumatsu T, Tateishi J Am J Pathol. 1994; 145(4):776-81.

PMID: 7524329 PMC: 1887323.


Bromodeoxyuridine labeling study of intracranial meningiomas: proliferative potential and recurrence.

Lee K, Hoshino T, Rodriguez L, Bederson J, Davis R, Wilson C Acta Neuropathol. 1990; 80(3):311-7.

PMID: 2399811 DOI: 10.1007/BF00294650.


Radiation-induced meningiomas and their proliferative activity. Cytokinetic study using bromodeoxyuridine.

Tashima T, Fukui M, Nishio S, Fujii K, Iwaki T Acta Neurochir (Wien). 1990; 102(1-2):69-72.

PMID: 2305653 DOI: 10.1007/BF01402189.

References
1.
Jellinger K, SLOWIK F . Histological subtypes and prognostic problems in meningiomas. J Neurol. 1975; 208(4):279-98. DOI: 10.1007/BF00312803. View

2.
Carella R, Ransohoff J, NEWALL J . Role of radiation therapy in the management of meningioma. Neurosurgery. 1982; 10(3):332-9. DOI: 10.1227/00006123-198203000-00006. View

3.
Simpson D . The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry. 1957; 20(1):22-39. PMC: 497230. DOI: 10.1136/jnnp.20.1.22. View

4.
Friedman M . Irradiation of meningioma: a prototype circumscribed tumor for planning high-dose irradiation of the brain. Int J Radiat Oncol Biol Phys. 1977; 2(9-10):949-58. DOI: 10.1016/0360-3016(77)90193-6. View

5.
Skullerud K, LOKEN A . The prognosis in meningiomas. Acta Neuropathol. 1974; 29(4):337-44. DOI: 10.1007/BF00685486. View